The effect of Roy Jelly on quality of life and health status

The effect of Roy Jelly on quality of life and health status of multiple sclerosis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160110025929N13

Enrollment

100

Registered

2018-06-02

Start date

2018-05-31

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis.. Multiple sclerosis

Interventions

Intervention 1: Intervention group: In the intervention group, a 500 mg capsule daily jelly gel containing substances such as 10-hydroxy-2-decenoic acid, B group vitamins, potassium, calcium, magnesiu

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age is between 18 and 60 years Have complete and informed consent to participate in the study Confirm Diagnosis of MS by the neurologist

Exclusion criteria

Exclusion criteria: Patient death Unwillingness to continue participating in the study

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: Before and after intervention. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
Health status. Timepoint: Before and after intervention. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhodayar oshvandi

Hamedan University of Medical Sciences

oshvandi2005@yahoo.com+98 81 3838 0535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026